Zydus Lifesciences Ltd

NSE: ZYDUSLIFE BSE: 532321

₹1070.80

(0.34%)

Sun, 21 Jun 2026, 05:41 am

MTF 5xInvest in Zydus Lifesciences Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)107757.6

PE Ratio21.38

Dividend1.03

Health Technology

Pharmaceuticals: Major

24.5K

Zydus Lifesciences News

Zydus completes ₹1,100 crore buyback

Zydus Lifesciences concluded its ₹1,100 crore share buyback, accepting 87.30 lakh shares at ₹1,260 each. The tender offer saw a subscription of 93.61 times.

18 Jun 2026

companies

Zydus completes Assertio acquisition

Zydus Lifesciences acquired 66.32% of Assertio Holdings at $23.50 per share. The merger completes on June 16, 2026.

16 Jun 2026

companies

Zydus Lifesciences Gets USFDA Warning Letter for Baddi Facility

Zydus Lifesciences received a USFDA warning letter for its Baddi facility over purified talc not meeting USP standards; current operations and supplies remain unaffected.

03 Jun 2026

companies

Zydus Lifesciences Gets US FDA Priority Review for Saroglitazar NDA

Zydus Lifesciences has received US FDA Priority Review for its New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC).

27 May 2026

companies

Zydus Lifesciences discloses share transmission

Zydus Lifesciences disclosed the transmission of 10,000 equity shares from a deceased promoter group member to Mr. Samar Babubhai Patel. The transaction was off-market and intimated to the company on May 25, 2026.

26 May 2026

companies

Showing 1–5 of 120

Rows per page:

Market Current News

Anubhav Plast IPO subscribed 1.2x

Anubhav Plast IPO subscribed 1.2x overall. QIB subscribed 1.01x, Retail 1.18x, and Non-Institutional Buyers saw strong demand.

19 Jun 2026

ipo

Jio Platforms to Offer 270 Million New Shares in IPO

Jio Platforms, a subsidiary of Reliance Industries, plans to offer 270 million new shares in an upcoming India IPO, marking a significant capital market development.

19 Jun 2026

ipo

QMS MEDICAL ALLIED S LTD

QMS Medical migrates to NSE Mainboard

QMS Medical Allied Services migrated 1.93 crore shares to NSE Mainboard. FY26 revenue stood at ₹172.9 crore with EBITDA of ₹25.9 crore.

18 Jun 2026

ipo

NSE files ₹30,000 crore DRHP

NSE filed a DRHP for a ₹30,000 crore Offer for Sale, set to be India's largest IPO. Shares will list on BSE.

18 Jun 2026

ipo

Dhanwel Hybrid Seeds IPO analysis

Dhanwel Hybrid Seeds IPO opens Jun 24, 2026, to raise ₹19.20 crore. Revenue grew 110% to ₹74.59 crore in FY26, but operating cash flows remain negative.

18 Jun 2026

ipo

Showing 1–5 of 93902

Rows per page: